The platinum-based cancer drugs market is projected to rise from USD 1.88 billion in 2026 to USD 2.73 billion by 2034, expanding at a CAGR of 4.30% during 2026 to 2034, with North America the largest market in 2025. Innovation is a central theme. Newer formulations such as liposomal platinum compounds aim to improve drug delivery to cancer cells while minimizing damage to healthy tissue....
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek